Abbott Laboratories (ABT)

114.25 +0.85 (+0.75%) USD  |  NYSE  |  Jan 08, 16:00
114.26 +0.01 (+0.01%) After-Hours: 20:00
More

Abbott Laboratories SG&A Expense (Quarterly): 2.895B for Sept. 30, 2024

SG&A Expense (Quarterly) Chart

View SG&A Expense (Quarterly) for ABT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

SG&A Expense Definition

View SG&A Expense Definition
Start Trial

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

View SG&A Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (Quarterly) Benchmarks

View SG&A Expense (Quarterly) Benchmarks
Start Trial
Boston Scientific Corp 1.562B
Haemonetics Corp 106.95M
ResMed Inc 238.98M
Globus Medical Inc 240.74M
Masimo Corp 184.80M